Resident Reflection Rounds
Noon Conference
Today, we took some time to reflect on our patient and personal experiences. What did you take away?
Reduced Cardiovascular and Renal Events with Canaglifozin (CANVAS + CANVAS-R)
EBM, Journal Club
Thank you, Alex, for a review of outcome data for one of the newest diabetes medications: canaglifozin (Invokana®). Canaglifozin is a SGLT2 inhibitor, which decreases reabsorption of glucose in the renal tubules. Clinical Question: Among patients with DM2 at high risk…
Time-to-Furosemide Treatment and Mortality in Patients Hospitalized with Acute Heart Failure
EBM, Journal Club
Key Discussion Points: Early treatment of acute heart failure with loop diuretics lowers mortality despite initial mortality risk, and this treatment strategy might be even more effective in high-risk AHF patients Earlier treatment/identification of acute heart failure relied heavily on…
Second Wednesday: Fall / AMA / Death
Night Float Curriculum
This post is protected. Please log in to view content.
Second Tuesday: Seizure
Night Float Curriculum
This post is protected. Please log in to view content.
Second Monday: Hyperglycemia / Hypoglycemia
Night Float Curriculum
This post is protected. Please log in to view content.
Second Sunday: Constipation / Nausea / Oliguria
Night Float Curriculum
This post is protected. Please log in to view content.
Second Saturday: Pain / Insomnia / Agitation
Night Float Curriculum
This post is protected. Please log in to view content.
Second Friday: Bleeding / Transfusion
Night Float Curriculum
This post is protected. Please log in to view content.
Second Thursday: Bradycardia
Night Float Curriculum
This post is protected. Please log in to view content.